VIGL - Vigil Neuroscience appoints Kaufmann as Chief Medical Officer
2024-03-20 07:50:35 ET
More on Vigil Neuroscience
- Vigil Neuroscience remains on track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024
- Seeking Alpha’s Quant Rating on Vigil Neuroscience
- Historical earnings data for Vigil Neuroscience
- Financial information for Vigil Neuroscience